NasdaqCM - Delayed Quote USD

BioRestorative Therapies, Inc. (BRTX)

1.2300 -0.0400 (-3.15%)
At close: April 25 at 4:00 PM EDT
1.2500 +0.02 (+1.63%)
Pre-Market: 8:00 AM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for BRTX

Recent News: BRTX

View More
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
GlobeNewswire 10 days ago
10 Micro-Cap Healthcare Stocks Insiders Are Buying

10 Micro-Cap Healthcare Stocks Insiders Are Buying
Insider Monkey 11 days ago
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
GlobeNewswire 18 days ago
BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants

BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants
GlobeNewswire 22 days ago
BioRestorative Therapies Full Year 2023 Earnings: Beats Expectations

BioRestorative Therapies Full Year 2023 Earnings: Beats Expectations
Simply Wall St. 23 days ago
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
GlobeNewswire 25 days ago
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference

BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
GlobeNewswire last month
Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock

Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock
Simply Wall St. 2 months ago
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting

BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
ACCESSWIRE 2 months ago
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market

BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
GlobeNewswire 2 months ago
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
GlobeNewswire 2 months ago
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting

BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
GlobeNewswire 2 months ago
View More

Related Tickers

SILO Silo Pharma, Inc.
1.8801
+0.01%
 
ALLR Allarity Therapeutics, Inc.
1.4300
+4.38%
 
DOMH Dominari Holdings Inc.
2.7000
-3.23%
 
PTN Palatin Technologies, Inc.
1.7200
-0.58%
 
PALI Palisade Bio, Inc.
6.23
-1.89%
 
ELYM Eliem Therapeutics, Inc.
3.3900
-7.38%
 
SNGX Soligenix, Inc.
0.4270
+11.49%
 
KZIA Kazia Therapeutics Limited
0.3699
-4.91%
 
FWBI First Wave BioPharma, Inc.
2.7300
-9.60%
 
CHRO Chromocell Therapeutics Corporation
1.5000
-4.46%